Balyasny Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.1M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $526K | Buy |
|
|||||
|
2024
Q4 | $190K | Sell |
|
|||||
|
2024
Q3 | $165K | Buy |
|
|||||
|
2024
Q2 | $43.5K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $290K | Sell |
|
|||||
|
2023
Q3 | $12.8M | Sell |
|
|||||
|
2023
Q2 | $25.3M | Buy |
|
|||||
|
2023
Q1 | $12.3M | Sell |
|
|||||
|
2022
Q4 | $23.9M | Buy |
|
|||||
|
2022
Q3 | $5.39M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $808K | Buy |
|